FDA Inspection 724836 — CP Pharmaceuticals Limited

CP Pharmaceuticals Limited — FEI 3003369660

The FDA completed an inspection of CP Pharmaceuticals Limited on May 13, 2011 in Wrexham. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 13, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wrexham (United Kingdom)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.